The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
The design of drugs for HIV and HCV
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
The in vitro micronucleus technique
Fenech, M. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(00)00065-8 · Cited by 2,510
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Wacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., & Rothman, N. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh075 · Cited by 1,754
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
On the road to cancer: aneuploidy and the mitotic checkpoint
Kops, G. J. P. L., Weaver, B. A. A., & Cleveland, D. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1714 · Cited by 1,185
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
Bonassi, S., Znaor, A., Ceppi, M., Lando, C., Chang, W. P., Holland, N., Kirsch-Volders, M., Zeiger, E., Ban, S., Barale, R., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl177 · Cited by 1,023
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Lamarre, D., Anderson, P. C., Bailey, M., Beaulieu, P., Bolger, G., Bonneau, P., Bös, M., Cameron, D. R., Cartier, M., Cordingley, M. G., et al. (2003) · Nature · doi:10.1038/nature02099 · Cited by 917
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Gallant, J. E., DeJesus, E., Arribas, J. R., Pozniak, A. L., Gazzard, B., Campo, R. E., Lu, B., McColl, D., Chuck, S., Enejosa, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051871 · Cited by 880
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B
Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V., & Goff, S. P. (1993) · Cell · doi:10.1016/0092-8674(93)90637-6 · Cited by 802
IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans
Albertini, R. J., Anderson, D., Douglas, G. R., Hagmar, L., Hemminki, K., Merlo, F., Natarajan, A. T., Norppa, H., Shuker, D. E. G., Tice, R., et al. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00049-1 · Cited by 790
Acyclic nucleoside phosphonates: a key class of antiviral drugs
Clercq, E. D., & Holý, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1877 · Cited by 688
Self-citationWatson, M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.275 · Cited by 668
Antiviral agents active against influenza A viruses
De Clercq, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2175 · Cited by 668
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Sarrazin, C., Kieffer, T. L., Bartels, D., Hanzelka, B., Müh, U., Welker, M., Wincheringer, D., Zhou, Y., Chu, H., Lin, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.037 · Cited by 616
Grinsztejn, B., Nguyen, B.-Y., Katlama, C., Gatell, J. M., Lazzarin, A., Vittecoq, D., Gonzalez, C. J., Chen, J., Harvey, C. M., & Isaacs, R. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60597-2 · Cited by 574
Isolation and Transmission of Human Retrovirus (Human T-Cell Leukemia Virus)
Popovic, M., Sarin, P. S., Robert-Gurroff, M., Kalyanaraman, V. S., Mann, D., Minowada, J., & Gallo, R. C. (1983) · Science · doi:10.1126/science.6600519 · Cited by 559
RESPONSE Re: Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
Berwick, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1537 · Cited by 545
Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review
Hung, R. J., Hall, J., Brennan, P., & Boffetta, P. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi318 · Cited by 525
Hein, D. W. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00153-7 · Cited by 518
Tantillo, C., Ding, J., Jacobo-Molina, A., Nanni, R. G., Boyer, P. L., Hughes, S. H., Pauwels, R., Andries, K., Janssen, P. A. J., & Arnold, E. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1665 · Cited by 518
Fätkenheuer, G., Pozniak, A. L., Johnson, M. A., Plettenberg, A., Staszewski, S., Hoepelman, A. I. M., Saag, M. S., Goebel, F. D., Rockstroh, J. K., Dezube, B. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1319 · Cited by 495
Streeter, D. G., Witkowski, J. T., Khare, G. P., Sidwell, R. W., Bauer, R. J., Robins, R. K., & Simon, L. N. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.4.1174 · Cited by 478
Peginterferon and Ribavirin for Chronic Hepatitis C
Hoofnagle, J. H., & Seeff, L. B. (2006) · New England Journal of Medicine · doi:10.1056/nejmct061675 · Cited by 476
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R., & Bolognesi, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1331 · Cited by 465
De Clercq, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1134 · Cited by 460
Cyclophilin B Is a Functional Regulator of Hepatitis C Virus RNA Polymerase
Watashi, K., Ishii, N., Hijikata, M., Inoue, D., Murata, T., Miyanari, Y., & Shimotohno, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.014 · Cited by 454
Polymorphisms in Genes Involved in Folate Metabolism and Colorectal Neoplasia: A HuGE Review
Sharp, L. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh066 · Cited by 442
Li, F., Goila-Gaur, R., Salzwedel, K., Kilgore, N. R., Reddick, M., Matallana, C., Castillo, A., Zoumplis, D., Martin, D. E., Orenstein, J. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234683100 · Cited by 426
Challenges and successes in developing new therapies for hepatitis C
De Francesco, R., & Migliaccio, G. (2005) · Nature · doi:10.1038/nature04080 · Cited by 411
Chen, J. C.-H., Krucinski, J., Miercke, L. J. W., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D., & Stroud, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150220297 · Cited by 404
Pavlović, D., Neville, D. C. A., Argaud, O., Blumberg, B., Dwek, R. A., Fischer, W. B., & Zitzmann, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031527100 · Cited by 390
Perni, R. B., Almquist, S. J., Byrn, R. A., Chandorkar, G., Chaturvedi, P. R., Courtney, L. F., Decker, C. J., Dinehart, K., Gates, C. A., Harbeson, S. L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.899-909.2006 · Cited by 386
Markowitz, M., Morales-Ramirez, J. O., Nguyen, B.-Y., Kovacs, C. M., Steigbigel, R. T., Cooper, D. A., Liporace, R., Schwartz, R., Isaacs, R., Gilde, L. R., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31802b4956 · Cited by 368
Westby, M., Smith-Burchnell, C., Mori, J., Lewis, M., Mosley, M., Stockdale, M., Dorr, P., Ciaramella, G., & Perros, M. (2007) · Journal of Virology · doi:10.1128/jvi.02006-06 · Cited by 350
Janssen, P. A. J., Lewi, P. J., Arnold, E., Daeyaert, F., de Jonge, M., Heeres, J., Koymans, L., Vinkers, M., Guillemont, J., Pasquier, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040840e · Cited by 347
Westby, M., Lewis, M., Whitcomb, J., Youle, M., Pozniak, A. L., James, I. T., Jenkins, T. M., Perros, M., & van der Ryst, E. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4909-4920.2006 · Cited by 337
Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs
Carroll, S. S., Tomassini, J. E., Bosserman, M., Getty, K., Stahlhut, M. W., Eldrup, A. B., Bhat, B., Hall, D., Simcoe, A. L., LaFemina, R., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210914200 · Cited by 335
Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
Sato, M., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Kawakami, H., Matsuzaki, Y., Watanabe, W., Yamataka, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600139 · Cited by 328
Cancer risks among BRCA1 and BRCA2 mutation carriers
Levy-Lahad, E., & Friedman, E. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603535 · Cited by 327
Chromosomal aberrations and SCEs as biomarkers of cancer risk
Norppa, H., Bonassi, S., Hansteen, I.-L., Hagmar, L., Strömberg, U., Rössner, P., Boffetta, P., Lindholm, C., Gundy, S., Lazutka, J., et al. (2006) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.05.030 · Cited by 293
Cytochrome P450 Gene Polymorphism and Cancer
Agundez, J. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335621 · Cited by 292
In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061
Lin, C., Lin, K., Luong, Y.-P., Rao, B. G., Wei, Y.-Y., Brennan, D. L., Fulghum, J. R., Hsiao, H.-M., Ma, S., Maxwell, J. P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313020200 · Cited by 288
Venkatraman, S., Bogen, S. L., Arasappan, A., Bennett, F., Chen, K., Jao, E., Liu, Y.-T., Lovey, R., Hendrata, S., Huang, Y., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060325b · Cited by 281
Paeshuyse, J., Kaul, A., De Clercq, E., Rosenwirth, B., Dumont, J., Scalfaro, P., Bartenschlager, R., & Neyts, J. (2006) · Hepatology · doi:10.1002/hep.21102 · Cited by 279
DeJesus, E., Berger, D., Markowitz, M., Cohen, C., Hawkins, T., Ruane, P., Elion, R., Farthing, C., Zhong, L., Cheng, A. K., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233308.82860.2f · Cited by 270 · cited 1×
“Initial clinical trials with elvitegravir have indicated that monotherapy for 10 days with twice-daily doses of 400 or 800 mg, or once daily dosing of 50 mg plus ritonavir, can achieve HIV-1 RNA reductions up to 2 log 10 copies per mL in treatment-naive and treatment-experienced patients, with an adverse event profile…”
Bonassi, S., Ugolini, D., Kirsch‐Volders, M., Strömberg, U., Vermeulen, R., & Tucker, J. D. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20115 · Cited by 261
Vingerhoets, J., Azijn, H., Fransen, E., De Baere, I., Smeulders, L., Jochmans, D., Andries, K., Pauwels, R., & de Béthune, M.-P. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12773-12782.2005 · Cited by 249
Gulick, R. M., Su, Z., Flexner, C., Hughes, M. D., Skolnik, P. R., Wilkin, T. J., Gross, R., Krambrink, A., Coakley, E., Greaves, W. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/518797 · Cited by 239
Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future
De Clercq, E. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490012 · Cited by 238
Lewis, S. J., & Davey Smith, G. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0196 · Cited by 235
Pozniak, A. L., Gallant, J. E., DeJesus, E., Arribas, J. R., Gazzard, B., Campo, R. E., Chen, S.-S., McColl, D., Enejosa, J., Toole, J. J., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000245886.51262.67 · Cited by 231
Atherosclerosis and Cancer: Common Molecular Pathways of Disease Development and Progression
ROSS, J. S., STAGLIANO, N. E., DONOVAN, M. J., BREITBART, R. E., & GINSBURG, G. S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03949.x · Cited by 228
Strizki, J. M., Tremblay, C., Xu, S., Wojcik, L., Wagner, N., Gonsiorek, W., Hipkin, R. W., Chou, C.-C., Pugliese-Sivo, C., Xiao, Y., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4911-4919.2005 · Cited by 213
Lin, K., Perni, R. B., Kwong, A. D., & Lin, C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1813-1822.2006 · Cited by 200
Hepatitis C therapeutics: current status and emerging strategies
Tan, S.-L., Pause, A., Shi, Y., & Sonenberg, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd937 · Cited by 197
Biswal, B. K., Cherney, M. M., Wang, M., Chan, L., Yannopoulos, C. G., Bilimoria, D., Nicolas, O., Bedard, J., & James, M. N. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413410200 · Cited by 195
Non-nucleoside Analogue Inhibitors Bind to an Allosteric Site on HCV NS5B Polymerase
Wang, M., Ng, K. K.-S., Cherney, M. M., Chan, L., Yannopoulos, C. G., Bedard, J., Morin, N., Nguyen-Ba, N., Alaoui-Ismaili, M. H., Bethell, R. C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209397200 · Cited by 193
Thier, R., Brüning, T., Roos, P. H., Rihs, H.-P., Golka, K., Ko, Y., & Bolt, H. M. (2003) · International Journal of Hygiene and Environmental Health · doi:10.1078/1438-4639-00209 · Cited by 191
Genotoxicity of environmental tobacco smoke: a review
Husgafvel-Pursiainen, K. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.06.004 · Cited by 186
Fenech, M., Bonassi, S., Turner, J., Lando, C., Ceppi, M., Chang, W. P., Holland, N., Kirsch-Volders, M., Zeiger, E., Bigatti, M. P., et al. (2003) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(02)00248-6 · Cited by 185
Hashibe, M., Boffetta, P., Zaridze, D., Shangina, O., Szeszenia-Dabrowska, N., Mates, D., Janout, V., Fabiánová, E., Bencko, V., Moullan, N., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0710 · Cited by 185
(1986) · Nature · doi:10.1038/321010a0 · Cited by 183
Wilkin, T. J., Su, Z., Kuritzkes, D. R., Hughes, M., Flexner, C., Gross, R., Coakley, E., Greaves, W., Godfrey, C., Skolnik, P. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511035 · Cited by 183
Rosenwirth, B., Billich, A., Datema, R., Donatsch, P., Hammerschmid, F., Harrison, R., Hiestand, P., Jaksche, H., Mayer, P., & Peichl, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1763 · Cited by 182
Origin of nuclear buds and micronuclei in normal and folate-deprived human lymphocytes
Lindberg, H. K., Wang, X., Järventaus, H., Falck, G. C.-M., Norppa, H., & Fenech, M. (2007) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.12.002 · Cited by 178
Bastaki, M., Huen, K., Manzanillo, P., Chande, N., Chen, C., Balmes, J. R., Tager, I. B., & Holland, N. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000199498.08725.9c · Cited by 173
Krönke, J., Kittler, R., Buchholz, F., Windisch, M. P., Pietschmann, T., Bartenschlager, R., & Frese, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3436-3446.2004 · Cited by 172
Kimura, M., Umegaki, K., Higuchi, M., Thomas, P., & Fenech, M. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.1.48 · Cited by 170
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings
Malcolm, R. K., Woolfson, A. D., Toner, C. F., Morrow, R. J., & McCullagh, S. D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki326 · Cited by 166
Di Marco, S., Volpari, C., Tomei, L., Altamura, S., Harper, S., Narjes, F., Koch, U., Rowley, M., De Francesco, R., Migliaccio, G., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505423200 · Cited by 165
De Clercq, E. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.241 · Cited by 163
Fenech, M. (2005) · Mutagenesis · doi:10.1093/mutage/gei040 · Cited by 158
Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide
Woolfson, A. D., Malcolm, K. R., Morrow, R. J., Toner, C. F., & McCullagh, S. D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.026 · Cited by 149
MacArthur, R. D., Novak, R. M., Peng, G., Chen, L., Xiang, Y., Hullsiek, K. H., Kozal, M. J., van den Berg-Wolf, M., Henely, C., Schmetter, B., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69861-9 · Cited by 139
Aka, P., Mateuca, R., Buchet, J., Thierens, H., & Kirsch‐Volders, M. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.002 · Cited by 137
Heredia, A., Amoroso, A., Davis, C. E. L. B., Le, N., Reardon, E., Dominique, J. K., Klingebiel, E., Gallo, R. C., & Redfield, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834278100 · Cited by 136
Short-term antiviral activity of TMC278 – a novel NNRTI – in treatment-naive HIV-1-infected subjects
Goebel, F. D., Yakovlev, A., Pozniak, A., Vinogradova, E., Boogaerts, G., Hoetelmans, R. M. W., de Béthune, M., Peeters, M., & Woodfall, B. (2006) · AIDS · doi:10.1097/01.aids.0000242818.65215.bd · Cited by 128
CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection
Westby, M., & van der Ryst, E. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600601 · Cited by 125
Summa, V., Petrocchi, A., Pace, P., Matassa, V. G., Francesco, R. D., Altamura, S., Tomei, L., Koch, U., & Neuner, P. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0342109 · Cited by 124
Adamson, C. S., Ablan, S. D., Boeraș, I., Goila-Gaur, R., Soheilian, F., Nagashima, K., Li, F., Salzwedel, K., Sakalian, M., Wild, C. T., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01369-06 · Cited by 122
Rapid Emergence of Enfuvirtide Resistance in HIV-1-Infected Patients: Results of a Clonal Analysis
Lü, J., Deeks, S. G., Hoh, R., Beatty, G. W., Kuritzkes, B. A., Martin, J. N., & Kuritzkes, D. R. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000234083.34161.55 · Cited by 114
Angelini, S., Kumar, R., Carbone, F., Maffei, F., Forti, G. C., Violante, F. S., Lodi, V., Curti, S., Hemminki, K., & Hrelia, P. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.10.007 · Cited by 113
Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects
Zijno, A. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg064 · Cited by 108
MTHFR C677T and colorectal cancer risk: A meta‐analysis of 25 populations
Hubner, R. A., & Houlston, R. S. (2006) · International Journal of Cancer · doi:10.1002/ijc.22440 · Cited by 106
Heuser, V. D., Erdtmann, B., Kvitko, K., Rohr, P., & da Silva, J. (2007) · Toxicology · doi:10.1016/j.tox.2007.01.011 · Cited by 105
Pauwels, R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.07.005 · Cited by 104
NQO1, MPO, and the risk of lung cancer: A HuGE review
Kiyohara, C., Yoshimasu, K., Takayama, K., & Nakanishi, Y. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000177530.55043.c1 · Cited by 104
Cytogenetic and molecular biomonitoring of a Portuguese population exposed to pesticides
Costa, C. (2006) · Mutagenesis · doi:10.1093/mutage/gel039 · Cited by 104
Mutations Conferring Resistance to SCH6, a Novel Hepatitis C Virus NS3/4A Protease Inhibitor
Yi, M., Tong, X., Skelton, A., Chase, R., Chen, T., Prongay, A., Bogen, S. L., Saksena, A. K., Njoroge, F. G., Veselenak, R. L., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510246200 · Cited by 104
Murga, J. D., Franti, M., Pevear, D. C., Maddon, P. J., & Olson, W. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00699-06 · Cited by 91
Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage
Botto, N., Andreassi, M. G., Manfredi, S., Masetti, S., Cocci, F., Colombo, M. G., Storti, S., Rizza, A., & Biagini, A. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201024 · Cited by 89
The Anti-Yellow Fever Virus Activity of Ribavirin Is Independent of Error-Prone Replication
Leyssen, P., Clercq, E. D., & Neyts, J. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020057 · Cited by 89
Self-citationHarper, S., Pacini, B., Avolio, S., Filippo, M. D., Migliaccio, G., Laufer, R., Francesco, R. D., Rowley, M., & Narjes, F. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049122i · Cited by 84
Thibeault, D., Bousquet, C., Gingras, R., Lagacé, L., Maurice, R., White, P. W., & Lamarre, D. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7352-7359.2004 · Cited by 84
Evaluation of genotoxic effects in a group of workers exposed to low levels of styrene
Laffón, B., Pásaro, E., & Méndez, J. (2002) · Toxicology · doi:10.1016/s0300-483x(01)00572-8 · Cited by 82
Paeshuyse, J., Leyssen, P., Mabery, E. M., Böddeker, N., Vrancken, R., Froeyen, M., Ansari, I. H., Dutartre, H., Rozenski, J., Gil, L. H. V. G., et al. (2005) · Journal of Virology · doi:10.1128/jvi.80.1.149-160.2006 · Cited by 82
Self-citationChromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers
Baeyens, A., Thierens, H., Claes, K., Poppe, B. G., Ridder, L. D., & Vral, A. (2004) · International Journal of Radiation Biology · doi:10.1080/09553000400017937 · Cited by 79
Martin, D. E., Blum, R. A., Wilton, J. H., Doto, J., Galbraith, H., Burgess, G. L., Smith, P. C., & Ballow, C. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01391-06 · Cited by 77
Gathe, J., Cooper, D. A., Farthing, C., Jayaweera, D. T., Norris, D., Pierone, G., Steinhart, C. R., Trottier, B., Walmsley, S. L., Workman, C., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508353 · Cited by 76
Mateuca, R., Aka, P. V., Boeck, M. D., et al. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2004.12.002 · Cited by 75
McHutchison, J. G., Patel, K., Pockros, P. J., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.009 · Cited by 75
Tuimala, J., Szekely, G., Wikman, H., Järventaus, H., Hirvonen, A., Gundy, S., & Norppa, H. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.009 · Cited by 74
Mouse models of XRCC1 DNA repair polymorphisms and cancer
Ladiges, W. (2006) · Oncogene · doi:10.1038/sj.onc.1209370 · Cited by 73
Ren, J., Nichols, C. E., Chamberlain, P. P., Weaver, K. L., Short, S. A., Chan, J. H., Kleim, J., & STAMMERS, D. K. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061117m · Cited by 69
Ray, N., Harrison, J. E., Blackburn, L. A., Martin, J. N., Deeks, S. G., & Doms, R. W. (2007) · Journal of Virology · doi:10.1128/jvi.02413-06 · Cited by 68
Ramanathan, S., Shen, G., Cheng, A., & Kearney, B. P. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318050d88c · Cited by 61
Chapel, C., Garcia, C., Roingeard, P., Zitzmann, N., Dubuisson, J., Dwek, R. A., TREPO, C. G., Zoulim, F., & Durantel, D. (2006) · Journal of General Virology · doi:10.1099/vir.0.81503-0 · Cited by 55
Tomei, L., Altamura, S., Paonessa, G., Francesco, R. D., & Migliaccio, G. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600403 · Cited by 55
Hang, J. Q., Li, Y., Yang, Y., Cammack, N., Mirzadegan, T., & Klumpp, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.018 · Cited by 54
Courcambeck, J., Bouzidi, M., Perbost, R., Jouirou, B., Amrani, N., Cacoub, P., Pèpe, G., Sabatier, J., & Halfon, P. (2006) · Antiviral Therapy · doi:10.1177/135965350601100702 · Cited by 54
Martin, D. E., Blum, R. A., Doto, J., Galbraith, H., & Ballow, C. H. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746070-00004 · Cited by 52
Antiviral, immunosuppressive and antitumour effects of Ribavirin
Potter, C. W., Phair, J., Vodinelich, L., FENTON, R., & Jennings, R. (1976) · Nature · doi:10.1038/259496a0 · Cited by 52
Labrosse, B., Morand‐Joubert, L., Goubard, A., Rochas, S., Labernardière, J., Pacanowski, J., Meynard, J., Hance, A. J., Clavel, F., & Mammano, F. (2006) · Journal of Virology · doi:10.1128/jvi.02706-05 · Cited by 51
A multi‐biomarker analysis of DNA damage in automobile painters
Testa, A., Festa, F., Ranaldi, R., Giachelia, M., Tirindelli, D., Marco, A. D., Owczarek, M., Guidotti, M., & Cozzi, R. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20147 · Cited by 51
Aspects of successful drug discovery and development
Pauwels, R. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.007 · Cited by 50
Increased micronucleus frequency in lymphocytes from smokers with lung cancer
Cheng, T., Christiani, D. C., Xu, X., Wain, J. C., Wiencke, J. K., & Kelsey, K. T. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00150-6 · Cited by 48
Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke
Palma, S., Cornetta, T., Padua, L., Cozzi, R., Appolloni, M., Ievoli, E., & Testa, A. (2007) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2007.03.014 · Cited by 47
Ishikawa, H., Ishikawa, T., Yamamoto, H., Fukao, A., & Yokoyama, K. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.11.026 · Cited by 46
DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
Kotsopoulos, J., Chen, Z., Vallis, K. A., Poll, A., Ainsworth, P., & Narod, S. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603528 · Cited by 46
Ji, C., Zhang, J., Dioszegi, M., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035055 · Cited by 45
Inhibition of Hepatitis C Virus Replication by Arsenic Trioxide
Hwang, D.-R., Tsai, Y.-C., Lee, J., Huang, K., Lin, R.-K., Ho, C.-H., Chiou, J., Lin, Y., Hsu, J. T.-A., & Yeh, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2876-2882.2004 · Cited by 44
Chromosomal mutagen sensitivity associated with mutations in BRCA genes
Speit, G., & Trenz, K. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077511 · Cited by 43
Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure
Neri, M., Filiberti, R., Taioli, E., GARTE, S. J., Paracchini, V., Bolognesi, C., Canessa, P. A., Fontana, V., Ivaldi, G. P., Verna, A., et al. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.06.003 · Cited by 39
Wen, Z., Martin, D. E., Bullock, P. L., Lee, K., & Smith, P. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012815 · Cited by 38
GSTM1, GSTT1, and GSTP1 genotypes and the genotoxicity of hydroquinone in human lymphocytes
Silva, M. D. C., Gaspar, J., Silva, I. D., Faber, A., & Rueff, J. (2004) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20015 · Cited by 37
Herschhorn, A., Lerman, L., Weitman, M., Gleenberg, I. O., Nudelman, A., & Hizi, A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0613121 · Cited by 36
Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility
Lindh, A. R., Rafii, S., Schultz, N., Cox, A., & Helleday, T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl037 · Cited by 36
Clercq, E. D. (2007) · PubMed · Cited by 34
Self-citationMontero, R. (2006) · Mutagenesis · doi:10.1093/mutage/gel040 · Cited by 34
Antiretroviral treatment of HIV infection: Swedish recommendations 2007
Josephson, F., Albert, J., Flamholc, L., Gisslén, M., Karlström, O., Lindgren, S.-R., Navér, L., Sandström, E., Svedhem, V., Svennerholm, B., et al. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701383154 · Cited by 32
From Adefovir to Atripla™ Via Tenofovir, Viread™ and Truvada™
Clercq, E. D. (2006) · Future Virology · doi:10.2217/17460794.1.6.709 · Cited by 32
Self-citationMigliore, L., Naccarati, A., Coppedè, F., Bergamaschi, E., Palma, G. D., Voho, A., Manini, P., Järventaus, H., Mutti, A., Norppa, H., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000182783.70006.44 · Cited by 29
The influence of GSTM1 null genotype on susceptibility to in vitro oxidative stress
Onaran, İ., Güven, G. S., Özaydın, A., & Ulutin, T. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00358-9 · Cited by 25
Daelemans, D., Lu, R., Clercq, E. D., & Engelman, A. (2007) · Journal of Virology · doi:10.1128/jvi.02637-06 · Cited by 23
Self-citationZijno, A., Verdina, A., Galati, R., Leopardi, P., Marcon, F., Andreoli, C., Rossi, S., & Crebelli, R. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.04.004 · Cited by 21
In Vitro Interactions between Apricitabine and Other Deoxycytidine Analogues
Bethell, R. C., de Muys, J.-M., Lippens, J., Richard, A., Hamelin, B. A., Ren, C., & Collins, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01204-06 · Cited by 20
Hatano, H., & Deeks, S. G. (2007) · BMJ · doi:10.1136/bmj.39205.386609.80 · Cited by 10
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 653
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Collins, P. J., Haire, L. F., Lin, Y. P., Liu, J., Russell, R. J., Walker, P. A., Skehel, J. J., Martin, S. R., Hay, A. J., & Gamblin, S. J. (2008) · Nature · doi:10.1038/nature06956 · Cited by 534
Fragment-Based Approaches in Drug Discovery and Chemical Biology
Scott, D. E., Coyne, A. G., Hudson, S. A., & Abell, C. (2012) · Biochemistry · doi:10.1021/bi3005126 · Cited by 460
Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
Murakami, E., Tolstykh, T., Bao, H., Niu, C., Steuer, H. M. M., Bao, D., Chang, W., Espiritu, C., Bansal, S., Lam, A. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.161802 · Cited by 291
Metadata
- Authors
- Clercq, E. D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-12
- Volume
- 6
- Issue
- 12
- Pages
- 1001-1018
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2136008225
- Cited by
- 430
- References
- 143
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.